Poseida Therapeutics Inc (NASDAQ:PSTX) price is hovering lower on Tuesday, April 16, dropping -11.52% below its previous close.
A look at today’s price movement shows that the recent level at last check reads $2.43. Taking into account the 52-week price action we note that the stock hit a 52-week high of $4.27 and 52-week low of $1.54. The stock subtracted -33.23% on its value in the past month.
Poseida Therapeutics Inc, which has a market valuation of $207.45 million. Analysts tracking PSTX have forecast the quarterly EPS to shrink by -0.42 per share this quarter, while the same analysts predict the annual EPS to hit -$1.67 for the year 2024 and up to -$1.8 for 2025. In this case, analysts estimate an annual EPS growth of -21.90% for the year and -7.80% for the next year.
On average, analysts have forecast the company’s revenue for the quarter will hit $11.67 million, with the likely lows of $7.5 million and highs of $15 million. The average estimate suggests sales growth for the quarter will likely rise by 12.80% when compared to those recorded in the same quarter in the last financial year. Staying with the analyst view, there is a consensus estimate of $46.67 million for the company’s annual revenue in 2024. Per this projection, the revenue is forecast to grow -27.90% below that which the company brought in 2024.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with — upward and — downward reviews. On the technical perspective front, indicators give PSTX a short term outlook of 50% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Buy, while an average of long term indicators are currently assigning the stock as 50% Sell.
The overview shows that PSTX’s price is at present -27.33% off the SMA20 and -35.23% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 30.58, with weekly volatility standing at 7.76%. The indicator jumps to 7.75% when calculated based on the past 30 days. Poseida Therapeutics Inc (NASDAQ:PSTX)’s beta value is holding at 0.45, while the average true range (ATR) indicator is currently reading 0.28.
An analysis of the Poseida Therapeutics Inc (NASDAQ:PSTX) stock in terms of its daily trading volume indicates that the 3-month average is 735.73K.
Current records show that the company has 95.64M in outstanding shares. The insiders’ percentage holdings are 35.96% of outstanding shares while the percentage share held by institutions stands at 47.08%. But the -36.01% downside, the stock’s price has registered year-to-date as of today’s value, will likely reignite investor interest given the prospect of it rallying even higher.
